Name

People Science

Legal name

PEOPLE SCIENCE, INC.

Website

https://peoplescience.health

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Decentralized Clinical Trial Platform

NAICS

Software Publishers (5132), Scientific Research and Development Services (5417)

SIC

Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)

akta.pro secondary industries

Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Decentralized clinical trials
• Clinical research platform
• Nutraceutical research
• Wearable health data
• Alternative medicine trials

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Chloe Clinical SaaS subscriptions: Software-as-a-Service licensing of the Chloe Clinical platform to enterprise customers (e.g., Persephone Biosciences). Recurring SaaS revenue from customers using Chloe as the sole software vendor for their decentralized clinical trials.
2. Clinical Research Services (full-service / professional services): Fee-for-service clinical research support including principal investigators, protocol design/consultation, data analysis, manuscript preparation and submission, study project management, participant coordination, IRB/ethics board management, vendor management (labs, test kits, wearables), rapid participant recruitment, and inventory/shipping logistics. Engagements appear to be project-based contracts for individual studies.
3. Chloe LiveLab collaborative research partnerships: Collaborative ingredient-brand research model with ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. Revenue model is partnership-driven, enabling joint promotional and evidence-generation activities (e.g., Phynova's Reducose® activation).

Pricing tiers

Go-to-market motion4 records

Distribution channels5 records

Marketing channels10 records

Core offering

People Science operates a proprietary technology platform called CHLOE (Consumer Health Learning & Organizing Ecosystem) that powers decentralized clinical trials for consumer health, dietary supplement, cannabis, microbiome, and women's health brands. The offering combines a participant-facing mobile app, a researcher/admin web portal, and a clinical operations SaaS backend with integrated wearables, home biomarker collection, and HIPAA/GDPR-compliant data handling. The company wraps this software stack with optional full-service clinical research services (principal investigators, protocol design, IRB management, recruitment, data analysis, manuscript preparation), so customers can buy SaaS-only self-build, full-service execution, or a hybrid — evidenced by named engagements with Persephone Biosciences (SaaS-only ARTEMIS trial), Mimio, Verb Biotics, Life Extension, Phylos, Saalt, and Sip2Sleep.

Product overview

People Science offers a unified clinical research platform — the CHLOE (Consumer Health Learning & Organizing Ecosystem) — delivered as a portfolio of coordinated modules rather than a single monolithic product. At the core sits Chloe Clinical, the decentralized clinical trial SaaS used to design and run protocol-driven research at scale with fully customizable forms, e-consent, wearables integration, and bio specimen collection. Layered on top is Chloe LiveLab, a collaborative ingredient-brand research model that turns randomized controlled trial designs into consumer-facing real-world evidence experiences. The participant-facing Chloe App ties the platform together, enabling enrollment, data entry, wearable sync, and results delivery. People Science also wraps these software modules with Clinical Research Services covering protocol design, IRB management, recruitment, data analysis, and manuscript preparation, so clients can engage at any level from SaaS-only self-build (as Persephone Biosciences did for the ARTEMIS trial) through full-service execution.

Differentiator

Problem solved

Functional benefit

Brands

• Chloe Clinical: A decentralized clinical trial software-as-a-service platform that supports protocol-driven research with a customizable mobile app, wearables integration, bio-specimen collection, and HIPAA-compliant infrastructure.
• Chloe LiveLab
• Chloe

Products and services

• Chloe Clinical A decentralized clinical trial software-as-a-service platform that enables protocol-driven research at any scale. Fully customizable, with high-quality data collection from an engaging participant mobile app, objective data collection through wearables integration (Oura, Garmin, Fitbit, Apple Watch, CGMs, smart scales) and bio specimen collections (blood, saliva, stool, urine, vaginal swabs), and HIPAA-compliant enterprise-grade security. Used by biotech sponsors (e.g., Persephone Biosciences ran the ARTEMIS infant synbiotic trial on it as sole software vendor) and supplement/cannabis brands for RCTs.
• Chloe LiveLab A collaborative ingredient-brand research model that collects real-world health data from customers to bolster product claims, enhance participant engagement, identify super-users, and strengthen evidence with objective and subjective data from photos, wearables, and surveys. Targets ingredient suppliers and consumer brands seeking real-world evidence for functional ingredients.
• Clinical Research Services Full-service research support offered alongside the Chloe platform: Scientific & Decentralized Trial Expertise (Principal Investigators, protocol design or consultation, data analysis, manuscript preparation and submission), Coordination & Management (study project management, participant coordination, IRB/Ethics board management, vendor management for labs, test kits, wearables), Operational Excellence (rapid participant recruitment, clinical study workflows, inventory and shipping logistics), and Flexible Approach to Science (RCTs, observational studies, baseline-controlled longitudinal studies, consumer insights).
• Chloe Consumer Health App The participant-facing mobile application that allows users to enroll in studies, complete e-Consent, log outcomes, sync wearable data, upload photos/videos/PDFs, view personal results, and receive communications for both Chloe Clinical and Chloe LiveLab studies. Distributed via Apple App Store and Google Play, free to participants enrolling in studies.

Named customers11 records

Segments6 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration15 records

AI capability5 records

Feature7 records

Partnerships

Six partnerships are on record, tiered flagship (early co-development partner), flagship, flagship (chloe livelab launch partner) and major.

• Woven Scienceflagship (early co-development partner)Strategic or Co-development PartnerAnnounced a partnership on November 1, 2022 to develop virtual clinical trials for alternative medicines, starting with a study on a cannabinoid product for sleep. Study leverages People Science's proprietary CHLOE™ platform and emphasizes a decentralized, home-based research model for cannabis and cannabinoid research aligned with expanding legalization and personalized wellness.
• Mimio HealthflagshipStrategic or Co-development PartnerCo-developed and published a randomized, double-blind, placebo-controlled clinical trial in Nature Scientific Reports (March 2, 2026) evaluating Mimio's novel "fasting mimetic" supplement. The 8-week study of 42 adults with elevated metabolic risk showed statistically significant improvements in cardiometabolic biomarkers (Total Cholesterol, LDL, Oxidized LDL, Fasting Glucose) and 91% improved appetite regulation. The decentralized trial was conducted entirely at participants' homes using People Science's Chloe platform.
• Phynovaflagship (chloe livelab launch partner)Strategic or Co-development PartnerCo-launched Chloe LiveLab at SupplySide Global in Las Vegas (announced Nov 4, 2025), a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. First activation features Phynova's clinically researched Reducose® ingredient for blood glucose management with live CGMs and the Chloe app. Plans to expand the model to additional functional ingredient categories.
• SaaltmajorStrategic or Co-development PartnerReleased consumer study findings (May 28, 2026) showing women were six times more likely to report no period cramping after switching from tampons to Saalt's reusable cups and discs. Decentralized study followed 188 participants across three menstrual cycles using the Chloe app; 78% reported overall symptom improvement and 95% would recommend the product. First-of-its-kind U.S. study on reusable menstrual products.
• Verb BioticsflagshipStrategic or Co-development PartnerTwo multi-study strategic partnership covering the Lp815 GABA probiotic. First, a 7-week decentralized RCT in 83 adults (anxiety) — published in Beneficial Microbes (April 24, 2025). Second, a 9-week decentralized RCT in 139 evaluable adults (sleep) — published in Nature Scientific Reports (Jan 19, 2026). Verb Biotics credits the partnership with enabling market expansion from anxiety into sleep.
• Persephone BiosciencesflagshipStrategic or Co-development PartnerPersephone uses Chloe Clinical as the sole software vendor for the ARTEMIS infant synbiotic study (contracted Aug 2024, IRB approval secured independently by Persephone, launched Jan 2025). 136 infants/toddlers aged 2–24 months enrolled; 80% adherence rate. ArtemIS is an IRB-approved RCT exploring tolerability and impact of a proprietary synbiotic (four probiotic strains + HMOs + Vitamin D) on infant/toddler gut microbiome, immune profile, and health outcomes.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Validic: Digital health platform aggregating wearable and connected-device data (Fitbit, Apple Health, Garmin, Oura, CGMs) for clinical trials and remote patient monitoring. Directly comparable to People Science's wearable integration layer, and an emerging competitor for the evidence-generation workflows People Science sells into consumer health trials.
• Sano Genetics: Software platform for decentralized clinical trials in genomics and rare disease with a participant-facing app and researcher portal. Comparable as a smaller, emerging DCT platform with overlapping technology architecture (mobile app + researcher backend) and a similar go-to-market motion targeting biotech and consumer health sponsors.

Regional players

• Seed Health: Microbiome-focused consumer probiotic company that has published clinical trials on its own products in peer-reviewed journals. Comparable to People Science's microbiome/probiotic customer segment (e.g., Verb Biotics), and an adjacent rather than directly competing company that could be a future People Science customer.

Direct peers

• REDCap: Free, open-source electronic data capture platform used by academic and biotech sponsors to build clinical trial databases. Cited explicitly in People Science's Persephone case study as the comparison point Chloe Clinical is positioned against — 'affordable vs alternatives like REDCap' with a consumer mobile UX that REDCap lacks.
• Medable: Enterprise decentralized clinical trial SaaS platform offering eCOA, eConsent, telehealth, and remote data capture on a unified cloud stack. Directly comparable to Chloe Clinical as a head-to-head DCT platform competitor, with substantially more capital, larger pharma reference customers, and a more mature enterprise sales motion.
• Castor: Cloud-based EDC and decentralized clinical trial platform with a self-serve SaaS model, electronic data capture, eConsent, and remote monitoring. Competes head-to-head with Chloe Clinical for mid-market and academic trial sponsors, particularly those who want a self-build SaaS alternative to full-service CRO offerings.
• Science37: Decentralized clinical trial platform operating in the same 'metasite' / DCT category as People Science's Chloe. Direct overlap on protocol-driven decentralized trials with consumer mobile apps and integrated wearables. Notable because Science37 was co-founded by People Science's own co-CEO Belinda Tan, making it both a direct competitor and an institutional reference point for the category.

Broad incumbents

• IQVIA: Largest global CRO with substantial decentralized clinical trial capabilities, technology platforms, and consumer-health evidence services. Competes with People Science for supplement, microbiome, and consumer health evidence-generation work at the enterprise end of the market, with materially more scale and pharma relationships.
• Veeva Systems: Enterprise cloud software for life sciences including Veeva Vault EDC, eTMF, and CTMS — the de facto incumbent for clinical trial software at large pharma. Broad incumbent with overlapping clinical operations capabilities, but no consumer-mobile-first or supplement/alternative-medicine focus.

Others

• Thorne: Vertically integrated supplement and wellness brand with its own clinical research arm, peer-reviewed scientific publications, and direct-to-consumer clinical engagement. Comparable as a customer-type for People Science's services (supplement brand investing in clinical evidence) rather than as a platform competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/people-science-co

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about People Science